Affordable Access

Progress in antibacterial and antifungal chemotherapy.

Authors
Type
Published Article
Journal
Drug News & Perspectives
0214-0934
Publisher
Thomson Reuters (Prous Science)
Publication Date
Volume
13
Issue
6
Pages
366–377
Identifiers
PMID: 12937659
Source
Medline
License
Unknown

Abstract

The European Society of Clinical Microbiology and Infectious Diseases sponsored the 10th European Congress on Clinical Microbiology and Infectious Diseases in Stockholm, Sweden, May 28-31, 2000. At the ECMID, well-attended sessions were held which focused on the pathogenesis and therapy of viral, bacterial and fungal diseases. This report focuses on new information on resistance to antibacterial agents, including data from recent surveillance studies, and the in vitro and investigational clinical activity of new antibacterial (moxifloxacin, telithromycin) and antifungal (fluconazole, itraconazole, voriconazole, amphotericin B, liposomal formulations of amphotericin B, terbinafine and the candins) drugs.

Statistics

Seen <100 times